DeNizio, Jamie E.
Verve Therapeutics (United States)
3 papers on CoChat
Most cited papers
- Verified
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Fraietta, J. A., Nobles, C. L., Sammons, M. A., Lundh, S., Carty, S. A., Reich, T. J., Cogdill, A. P., Morrissette, J. J. D., DeNizio, J. E., Reddy, S., et al. (2018) · Nature
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 862
- Verified
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P., DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., et al. (2021) · Nature
CRISPR and Genetic EngineeringLipoproteins and Cardiovascular Health
Cited by 793
- Verified
TET-TDG active DNA demethylation at CpG and non-CpG sites
DeNizio, J. E., Dow, B. J., Serrano, J. C., Ghanty, U., Drohat, A. C., & Kohli, R. M. (2021) · Journal of Molecular Biology
Epigenetics and DNA MethylationDNA Repair Mechanisms
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free